Ironwood Pharmaceuticals | IRWD - Trade Creditors


Ironwood Pharmaceuticals reported $1.61M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
Agios Pharmaceuticals USD 19.55M 2.02M Sep/2025
Almirall EUR 199.39M 50.03M Jun/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Amarin USD 36.71M 8M Sep/2025
Ardelyx USD 18.39M 3.29M Sep/2025
Astellas Pharma JPY 181.95B 13.3B Dec/2025
AstraZeneca USD 25.03B 1.04B Sep/2025
Charles River Laboratories USD 169.61M 23.82M Sep/2025
Exact Sciences USD 129.36M 27.97M Sep/2025
Halozyme Therapeutics USD 15.36M 3.33M Sep/2025
Incyte USD 171.92M 1.24B Sep/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Moderna USD 267M 92M Sep/2025
Myriad Genetics USD 31.8M 900K Sep/2025
Pacira USD 17.69M 12.44M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Takeda JPY 467.59B 28.61B Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025